Cancer biomarker sensor based on graphene oxide-integrated excessively tilted fiber grating LSPR

被引:0
作者
Luo B.-B. [1 ]
Gu H. [1 ]
Lü Q.-M. [1 ]
Wang Y.-J. [1 ]
Wu S.-X. [2 ]
机构
[1] Chongqing Key Laboratory of Optical Fiber Sensor and Photoelectric Detection, Chongqing University of Technology, Chongqing
[2] School of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing
来源
Guangxue Jingmi Gongcheng/Optics and Precision Engineering | 2021年 / 29卷 / 09期
关键词
Excessively tilted fiber grating; Graphene oxide; Hepatocellular carcinoma; Local surface plasmon resonance; Optical fiber sensing; Programmed cell death ligand 1;
D O I
10.37188/OPE.20212909.2039
中图分类号
学科分类号
摘要
This study proposed a graphene oxide (GO)-integrated excessively tilted fiber grating (ExTFG) local surface plasmon resonance (LSPR) immunosensor for the label-free and specific detection of the cancer biomarker programmed cell death-ligand 1 (PD-L1). First, large-sized (165 nm) gold nanoshells were used as LSPR carriers to be immobilized on the fiber surface; then, GO was coated on the fiber surface to improve the hydrophobic properties of the ExTFG-LSPR sensor to enhance the sensor's ability to adsorb biomolecular proteins. Finally, anti-PD-L1 monoclonal antibodies were covalently bound to the carboxyl terminal of the GO on the fiber surface for the specific detection of PD-L1. Experimental results showed that the detection range of the immunosensor for PD-L1 antigens in phosphate buffer is 0.038-38.46 pmol/L, exhibiting suitable linearity in the low concentration region of 0-2 pmol/L with a sensitivity of approximately 0.114 nm/(pmol·L-1). The detection limit of the immunosensor for the PD-L1 antigen dissolved in phosphate buffer is as low as approximately 0.076 pmol/L, and the dissociation coefficient is approximately 2.801×10-12 mol/L. When the immunosensor was used in clinical immunoassays with different healthy serum samples and hepatocellular carcinoma serum samples, its responses to the former were extremely weak but were noticeable toward the latter, indicating that it had suitable clinical specificity for PD-L1 in complex serum environments and thus showed potential for clinical application. © 2021, Science Press. All right reserved.
引用
收藏
页码:2039 / 2047
页数:8
相关论文
共 26 条
[1]  
GREENWALD R J, FREEMAN G J, SHARPE A H., The B7family revisited [J], Annual Review of Immunology, 23, 1, pp. 515-548, (2005)
[2]  
YOSHIKO I, SERGOG T, MASAYA I, Et al., PD-1 inhibits antiviral immunity at the effector phase in the liver [J], The Journal of Experimental Medicine, 198, 1, pp. 39-50, (2003)
[3]  
CALDERARO J, ROUSSESU B, AMDDEO G, Et al., Programmed death ligand 1 expression in hepatocellular carcinoma: relationship with clinical and pathological features, Hepatology, 6, 64, pp. 2038-2046, (2016)
[4]  
QU H X, ZHAO L P, ZHAN H S, Et al., Clinicopathological and prognostic significance of programmed cell death ligand 1 (pd-l1) expression in patients with esophageal squamous cell carcinoma: a meta-analysis [J], Journal of Thoracic Disease, 8, 11, pp. 3197-3204, (2016)
[5]  
GIUILIANA C, ROUSSEAU B, AMADDEO G, Et al., Programmed death ligand 1 expression in hepatocellular carcinoma: relationship with clinical and pathological features, Hepatology Official Journal of the American Association for the Study of Liver Diseases, 6, 64, pp. 2038-2046, (2016)
[6]  
MANSON Q F, NATALIE D, HOEVE T, Et al., Pd-1 and pd-l1 expression in male breast cancer in comparison with female breast cancer [J], Targeted Oncology, 13, 6, pp. 769-777, (2018)
[7]  
FINKELMEIER F, CANIL O, TAL A, Et al., High levels of the soluble programmed death-ligand (sPD-L1) identify hepatocellular carcinoma patients with a poor prognosis [J], Cancer, 59, pp. 152-159, (2016)
[8]  
TAN D, LI S, YI Q H, Correlation of PD-1/PD-L1 polymorphisms and expressions with clinicopathologic features and prognosis of ovarian cancer [J], Cancer Biomarkers, 21, 2, pp. 287-297, (2018)
[9]  
SHI SH H, WANG X, ZHAO M F, Et al., Sensing characteristics of period fiber grating functionalized with graphite oxide, Opt. Precision Eng, 27, 11, pp. 2305-2313, (2019)
[10]  
SHI J S, YU Y H, WANG M J, Et al., Application of optical fiber biosensor in quantitative detection of HER3 antibody, Chinese Optics, 11, pp. 503-512, (2018)